Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B GOTTLIEB

Showing results (281-290 of 523) with videos related to

Pageof 53
Sort By:
Journal of Cutaneous Medicine and Surgery|May 16, 2006
Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis: review of clinical data. part IIKim A Papp, Charles Camisa, Stephen P Stone, et al.
Journal of the American Academy of Dermatology|February 21, 2006
Relapse, rebound, and psoriasis adverse events: an advisory group reportWayne Carey, Scott Glazer, Alice B Gottlieb, et al.
Dermatology and Therapy|December 6, 2017
The Development of the Genital Psoriasis Sexual Frequency Questionnaire (GenPs-SFQ) to Assess the Impact of Genital Psoriasis on Sexual HealthAlice B Gottlieb, Brian Kirby, Caitriona Ryan, et al.
Revista Medica De Chile|May 15, 2001
[A new instrument for the evaluation of the medical profession. Use of the OSCE method]M Bustamante, C Carvajal, B Gottlieb, et al.
The British Journal of Dermatology|July 10, 2019
Sustained efficacy of secukinumab in patients with moderate-to-severe palmoplantar psoriasis: 2·5-year results from GESTURE, a randomized, double-blind, placebo-controlled trialA B Gottlieb, A Kubanov, M van Doorn, et al.
BMC Rheumatology|December 5, 2019
Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologicsChristopher T Ritchlin, Mona Stahle, Yves Poulin, et al.
The British Journal of Dermatology|July 8, 2015
Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligoK C Webb, R Tung, L S Winterfield, et al.
The British Journal of Dermatology|July 17, 2008
Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasisS R Feldman, A B Gottlieb, M Bala, et al.
Journal of the American Academy of Dermatology|April 19, 2011
Psoriasis in the elderly: from the Medical Board of the National Psoriasis FoundationIvan S Grozdev, Abby S Van Voorhees, Alice B Gottlieb, et al.
The Journal of Rheumatology|July 2, 2004
Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanerceptPhillip J Mease, Christopher T Ritchlin, Richard W Martin, et al.
Pageof 53

Showing results (281-290 of 523) with videos related to

Sort By:
Pageof 53
Journal of Cutaneous Medicine and Surgery|May 16, 2006
Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis: review of clinical data. part IIKim A Papp, Charles Camisa, Stephen P Stone, et al.
Journal of the American Academy of Dermatology|February 21, 2006
Relapse, rebound, and psoriasis adverse events: an advisory group reportWayne Carey, Scott Glazer, Alice B Gottlieb, et al.
Dermatology and Therapy|December 6, 2017
The Development of the Genital Psoriasis Sexual Frequency Questionnaire (GenPs-SFQ) to Assess the Impact of Genital Psoriasis on Sexual HealthAlice B Gottlieb, Brian Kirby, Caitriona Ryan, et al.
Revista Medica De Chile|May 15, 2001
[A new instrument for the evaluation of the medical profession. Use of the OSCE method]M Bustamante, C Carvajal, B Gottlieb, et al.
The British Journal of Dermatology|July 10, 2019
Sustained efficacy of secukinumab in patients with moderate-to-severe palmoplantar psoriasis: 2·5-year results from GESTURE, a randomized, double-blind, placebo-controlled trialA B Gottlieb, A Kubanov, M van Doorn, et al.
BMC Rheumatology|December 5, 2019
Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologicsChristopher T Ritchlin, Mona Stahle, Yves Poulin, et al.
The British Journal of Dermatology|July 8, 2015
Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligoK C Webb, R Tung, L S Winterfield, et al.
The British Journal of Dermatology|July 17, 2008
Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasisS R Feldman, A B Gottlieb, M Bala, et al.
Journal of the American Academy of Dermatology|April 19, 2011
Psoriasis in the elderly: from the Medical Board of the National Psoriasis FoundationIvan S Grozdev, Abby S Van Voorhees, Alice B Gottlieb, et al.
The Journal of Rheumatology|July 2, 2004
Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanerceptPhillip J Mease, Christopher T Ritchlin, Richard W Martin, et al.
Pageof 53